Last reviewed · How we verify

NCT04447170: LOREPUP

Laparoscopic Versus Open Repair of Peptic Ulcer Perforation

Status unknown Last updated 29 December 2021
What this trial tests

trial testing Simple repair or Graham technique in Surgery in 200 participants. Status unknown.

Timeline
1 January 2017
Primary endpoint
30 November 2021
1 April 2022

Quick facts

Lead sponsorGianluca Costa
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment200
Start date1 January 2017
Primary completion30 November 2021
Estimated completion1 April 2022
Sites13 locations across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Gianluca Costa

Who can join

18 and older, any sex, with Surgery or Emergencies. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Although laparoscopic repair (LR) of perforated peptic ulcers (PPUs) has long been accepted, clinical evidence comparing LR versus open repair (OR) remains lacking. The aim of this study is to evaluate the feasibility, safety and outcome of laparoscopic gastric repair and compare it with the outcome open repair by relying on a propensity score matching statistical technique

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Surgery

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04447170.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing